Literature DB >> 25175081

Mucormycosis in children: a study of 22 cases in a Mexican hospital.

Alexandro Bonifaz1, Andrés Tirado-Sánchez, Luz Calderón, Raúl Romero-Cabello, Juan Kassack, Rosa María Ponce, Carlos Mena, Alberto Stchigel, Josep Cano, Josep Guarro.   

Abstract

We present a single-centre, retrospective study (1985-2012) of 22 cases of mucormycosis in children. A total of 158 mucormycosis cases were identified, of which 22 (13.96%) were children. The mean age of the children was 10.3 years (range: 6 months-18 years), and 59% of the infections occurred in males. The rhinocerebral form was the main clinical presentation (77.27%), followed by the primary cutaneous and pulmonary patterns. The major underlying predisposing factors were diabetes mellitus in 68.18% of the patients and haematologic diseases in 27.7% of the patients. The cases were diagnosed by mycological tests, with positive cultures in 95.4% of the patients. Rhizopus arrhizus was the foremost aetiologic agent in 13/22 cases (59.1%). In 21 cultures, the aetiologic agents were identified morphologically and by molecular identification. In 10 cultures, the internal transcribed spacer region of the ribosomal DNA was sequenced. Clinical cure and mycological cure were achieved in 27.3% cases, which were managed with amphotericin B deoxycholate and by treatment of the underlying conditions.
© 2014 Blackwell Verlag GmbH.

Entities:  

Keywords:  Mucormycosis; children; diabetes mellitus; haematological malignancy; rhinocerebral; zygomycosis

Mesh:

Substances:

Year:  2014        PMID: 25175081     DOI: 10.1111/myc.12233

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  7 in total

1.  Photoletter to the editor: Atypical primary cutaneous mucormycosis of the scalp.

Authors:  Ricardo García-Sepúlveda; Josefina Navarrete-Solís; Hiram Villanueva-Lozano; Rogelio de J Treviño-Rangel; Gloria M González; Jorge Enríquez-Rojas; Javier Molina-Durazo; Roberto Arenas-Guzmán
Journal:  J Dermatol Case Rep       Date:  2017-12-01

Review 2.  Primary Cutaneous Mucormycosis Caused by Rhizopus oryzae: A Case Report and Review of Literature.

Authors:  Erika Rodríguez-Lobato; Lourdes Ramírez-Hobak; Jorge E Aquino-Matus; Juan P Ramírez-Hinojosa; Víctor H Lozano-Fernández; Juan Xicohtencatl-Cortes; Rigoberto Hernández-Castro; Roberto Arenas
Journal:  Mycopathologia       Date:  2016-11-03       Impact factor: 2.574

3.  Use of Fungal Diagnostics and Therapy in Pediatric Cancer Patients in Resource-Limited Settings.

Authors:  Sheena Mukkada; Jeannette Kirby; Nopporn Apiwattanakul; Randall T Hayden; Miguela A Caniza
Journal:  Curr Clin Microbiol Rep       Date:  2016-04-18

4.  Successful therapy of progressive rhino-orbital mucormycosis caused by Rhizopus arrhizus with combined and sequential antifungal therapy, surgery and hyperbaric therapy.

Authors:  Adrián Imbernón; José Luis Agud; María Soledad Cuétara; José Carlos Casqueiro; Pilar Nuñez; Alegría R Domínguez; Eusebio Bullido; Alberto M Stchigel
Journal:  Med Mycol Case Rep       Date:  2014-10-05

5.  Estimated Burden of Fungal Infections in Oman.

Authors:  Abdullah M S Al-Hatmi; Mohammed A Al-Shuhoumi; David W Denning
Journal:  J Fungi (Basel)       Date:  2020-12-23

6.  Development of a Monoclonal Antibody and a Serodiagnostic Lateral-Flow Device Specific to Rhizopus arrhizus (Syn. R. oryzae), the Principal Global Agent of Mucormycosis in Humans.

Authors:  Genna E Davies; Christopher R Thornton
Journal:  J Fungi (Basel)       Date:  2022-07-21

7.  Epidemiology, clinical features, therapeutic interventions and outcomes of mucormycosis in Shiraz: an 8-year retrospective case study with comparison between children and adults.

Authors:  Marjan Motamedi; Zahra Golmohammadi; Somayeh Yazdanpanah; S Mojtaba Saneian; Mojtaba Shafiekhani
Journal:  Sci Rep       Date:  2022-10-13       Impact factor: 4.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.